“…All mice received a tail vein injection once a day for 3 days. The db/+-NS group comprised control mice receiving saline (0.9%; same volume as the experimental group) injections [14,15,17,18], and the db/db-NS group comprised DM mice receiving saline (0.9%; same volume as the experimental group) injections [14,15,17,18]; the db/db-si-Rspo3 mice received injections of Rspo3 siRNA (80 mg/kg body weight, 14,15,17,18), and the db/db-agmiR-380-5p mice received injections of agmiR-380-5p (80 mg/kg body weight, 14,15,17,18). In each group, six mice were euthanized with an intraperitoneal injection of ketamine/xylazine (100/10 mg/kg body weight) on day 0 (prior to injection), day 2, day 4, and day 6 for further study.…”